Literature DB >> 28655776

Protein Sam68 regulates the alternative splicing of survivin DEx3.

Javier Gaytan-Cervantes1, Carolina Gonzalez-Torres2, Vilma Maldonado2, Cecilia Zampedri1, Gisela Ceballos-Cancino3, Jorge Melendez-Zajgla4.   

Abstract

Messenger RNA alternative splicing (AS) regulates the expression of a variety of genes involved in both physiological and pathological processes. AS of the anti-apoptotic and proliferation-associated survivin (BIRC5) gene generates six isoforms, which regulate key aspects of cancer initiation and progression. One of the isoforms is survivin DEx3, in which the exclusion of exon 3 generates a unique carboxyl terminus with specific anti-apoptotic functions. This isoform is highly expressed in advanced stages of breast and cervical tumors. Therefore, understanding the mechanisms that regulate survivin DEx3 mRNA AS is clearly important. To this end, we designed a minigene (M), and in combination with a series of deletions and site-directed mutations, we determined that the first 22 bp of exon 3 contain cis-acting elements that enhance the exclusion of exon 3 to generate the survivin DEx3 mRNA isoform. Furthermore, using pulldown assays, we discovered that Sam68 is a possible trans-acting factor that binds to this region and regulates exon 3 splicing. This result was corroborated using a cell line in which the Sam68 binding site in the survivin gene was mutated with the CRISPR/Cas system. This work provides the first clues regarding the regulation of survivin DEx3 mRNA splicing.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  KHDRBS1; Sam68; alternative splicing; cancer; cancer biology; gene regulation; survivin; survivin DEx3

Mesh:

Substances:

Year:  2017        PMID: 28655776      PMCID: PMC5566528          DOI: 10.1074/jbc.M117.800318

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Deciphering the splicing code.

Authors:  Yoseph Barash; John A Calarco; Weijun Gao; Qun Pan; Xinchen Wang; Ofer Shai; Benjamin J Blencowe; Brendan J Frey
Journal:  Nature       Date:  2010-05-06       Impact factor: 49.962

2.  Use of minigene systems to dissect alternative splicing elements.

Authors:  Thomas A Cooper
Journal:  Methods       Date:  2005-12       Impact factor: 3.608

3.  Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones.

Authors:  Xiang-Yang Zhong; Jian-Hua Ding; Joseph A Adams; Gourisankar Ghosh; Xiang-Dong Fu
Journal:  Genes Dev       Date:  2009-02-15       Impact factor: 11.361

Review 4.  Survivin, a cancer target with an emerging role in normal adult tissues.

Authors:  Seiji Fukuda; Louis M Pelus
Journal:  Mol Cancer Ther       Date:  2006-05       Impact factor: 6.261

Review 5.  Alternative splicing at the right time.

Authors:  Sabrina E Sanchez; Ezequiel Petrillo; Alberto R Kornblihtt; Marcelo J Yanovsky
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

6.  Survivin isoform Delta Ex3 regulates tumor spheroid formation.

Authors:  Magali Espinosa; Gisela Ceballos-Cancino; Richard Callaghan; Vilma Maldonado; Nelly Patiño; Víctor Ruíz; Jorge Meléndez-Zajgla
Journal:  Cancer Lett       Date:  2011-12-08       Impact factor: 8.679

Review 7.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

Review 8.  New wirings in the survivin networks.

Authors:  D C Altieri
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

9.  hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.

Authors:  Indrani Talukdar; Supriya Sen; Rodolfo Urbano; James Thompson; John R Yates; Nicholas J G Webster
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

10.  Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.

Authors:  M-H Malcles; H-W Wang; A Koumi; Y-H Tsai; M Yu; A Godfrey; C Boshoff
Journal:  Br J Cancer       Date:  2007-05-15       Impact factor: 7.640

View more
  5 in total

1.  Proteomics analysis of proteins interacting with heat shock factor 1 in squamous cell carcinoma of the cervix.

Authors:  Lingli Zhang; Zhe Hu; Ying Zhang; Jinzhi Huang; Xuefen Yang; Jiafeng Wang
Journal:  Oncol Lett       Date:  2019-06-27       Impact factor: 2.967

Review 2.  Advances in the study of RNA-binding proteins in diabetic complications.

Authors:  Xinyue Chen; Jiaqiang Wu; Zhangwang Li; Jiashu Han; Panpan Xia; Yunfeng Shen; Jianyong Ma; Xiao Liu; Jing Zhang; Peng Yu
Journal:  Mol Metab       Date:  2022-05-18       Impact factor: 8.568

Review 3.  The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer.

Authors:  Andrea Cerasuolo; Luigi Buonaguro; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Front Cell Dev Biol       Date:  2020-06-12

4.  Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51.

Authors:  Alice Turdo; Miriam Gaggianesi; Simone Di Franco; Veronica Veschi; Caterina D'Accardo; Gaetana Porcelli; Melania Lo Iacono; Irene Pillitteri; Francesco Verona; Gabriella Militello; Alessio Zippo; Vittoria Poli; Luca Fagnocchi; Sven Beyes; Stefania Stella; Rossano Lattanzio; Naida Faldetta; Vincenzo L Lentini; Rossana Porcasi; Giuseppe Pistone; Maria Rita Bongiorno; Giorgio Stassi; Ruggero De Maria; Matilde Todaro
Journal:  Oncogene       Date:  2022-02-25       Impact factor: 9.867

Review 5.  Splicing regulatory factors in breast cancer hallmarks and disease progression.

Authors:  Esmee Koedoot; Liesanne Wolters; Bob van de Water; Sylvia E Le Dévédec
Journal:  Oncotarget       Date:  2019-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.